Published November, 2019
By Richard T. Silver and Ayalew Tefferi
Publisher: Taylor & Francis (CRC Press)
Rating: 1.00
Availability: Available

With the recent discovery of JAK2 mutations in myeloproliferative disorders, medical science has taken a revolutionary stride forward toward understanding the pathogenesis of these diseases. This new advancement translates not only to a more rapid and reliable diagnosis, but also allows groundbreaking research into the development of new therapeuti

---

Published November, 2019
By Karim Fizazi
Publisher: Taylor & Francis (CRC Press)
Rating:
Availability: Available

Filling a gap in the literature, this guide provides expert recommendations and research on carcinoma of an unknown primary site (CUP). Covering the identification, diagnosis, and management of CUP with illustrative and reader-friendly clinical case examples, this reference helps physicians treat patients whose primary cancer site is difficult to

---

Published November, 2019
By Marco Chinol and Giovanni Paganelli
Publisher: Taylor & Francis (CRC Press)
Rating:
Availability: Available

Offering lower toxicity and higher accuracy than conventional therapies, this source offers illustrative coverage of this new method to treat tumors associated with brain, breast, lung, and neuroendocrine cancers. Accompanied by a CD offering color images, radiolabeling procedures, and tips on radiopharmceutical administration, this source will of

---

Published November, 2019
By Ashish Dwivedi, Neeraj Agarwal, Amit Kumar Tripathi and Lipika Ray
Publisher: Springer (Springer Verlag, Singapore)
Rating: 3.00
Availability: Available

This protection can be compromised by the aging of the skin which ultimately promotes skin inflammation, impaired wound repair, and increased risk of skin cancer.

---

Published November, 2019
By Daniel M Albert and Arthur Polans
Publisher: Taylor & Francis (CRC Press)
Rating: 1.00
Availability: Available

This book focuses on uveal melanoma and retinoblastoma, the principal tumors originating in the eyes of adults and children, respectively. It discusses the current status of clinical trials in ocular oncology and provides a review of risk and prognostic factors associated with eye tumors.

---

Published November, 2019
By Meletios A. Dimopoulos, Thierry Facon and Evangelos Terpos
Publisher: Springer (Springer Nature Switzerland AG)
Rating: 1.00
Availability: Available

Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration.

---

Published November, 2019
By Prajakta Dandekar, Padma V. Devarajan, Anisha A. D'Souza and Anisha D'Souza
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available

This book elaborates on drug delivery targeting via intracellular delivery, specifically through the Receptor Mediated Endocytosis (RME) approach, due to the involvement of cellular receptors in various grave diseases.

---

Published November, 2019
By Dennis A. Tighe, Dennis Tighe, Byron Gentile, Bryon A. Gentile and D Tighe
Publisher: John Wiley & Sons Ltd (Wiley-Blackwell)
Rating:
Availability: Available

---

Published November, 2019
By Deepak Kademani
Publisher: Springer (Springer Nature Switzerland AG)
Rating: 1.00
Availability: Available

This book brings together experts in the field of maxillofacial and head and neck oncology to provide a comprehensive clinical and translational update on oral cancer that focuses especially on prognosis.

---

Published November, 2019
By Whitney B. Pope
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available

---